PTC is committed to bringing hope to patients with rare and genetic diseases.
Our scientists are finding new ways to regulate biology to control disease.
We are developing new treatments for Duchenne Muscular Dystrophy, Cystic Fibrosis and other diseases.
About PTC Clinical Trials Careers at PTC PTC STRIVE Awards Program
German Federal Joint Committee Issues Positive Medical Benefit Rating For Translarna™ In Patients With Nonsense Mutation Duchenne Muscular Dystrophy
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics Launches Strive Grant Award Program
View all latest news